tirzepatide news october 2025 FDA Says Compounded Must Exit the Market ADA 2025: Advances in Type

ZouYSunXYangQZhengMShimoniORuanWet alBlood-brain barrierpenetrating single CRISPR-Cas9 nanocapsules for effective and safe glioblastoma gene therapy

Fella Health will help you determine if your insurance provider covers GLP-1s

For investors, the obvious question is whether pills will eventually make injections obsolete

However, in infants born to people with type 2 diabetes who took a second-line noninsulin antidiabetic medication including GLP-1 receptor agonists the study did not find a greater major congenital malformation risk compared to infants exposed to insulin

This approach identifies not just whether a patient should consider GLP-1 therapy like semaglutide injection ($189/month), but which formulation, dosing strategy, and complementary compounds optimize outcomes